This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gibson, S. L. Articles by Hilf, R. Search for Related Content PubMed PubMed Citation Articles by Gibson, S. L. Articles by Hilf, R.

Effects of Various Photoradiation Regimens on the Antitumor Efficacy of Photodynamic Therapy for R3230AC Mammary Carcinomas¹

University of Rochester School of Medicine and Dentistry, Departments of Biochemistry [S. L. G., K. R. V., R. S. M., R. H.] and Biostatistics [R. F. R.] and the University of Rochester Cancer Center [R. F. R., R. H.], Rochester, New York 14642

Clinical photodynamic therapy consists of the systemic administration of a derivative of hematoporphyrin (Photofrin II) followed by exposure of malignant lesions to continuous visible laser irradiation. We investigated the effects of various modifications of laser light delivery on the efficacy of photodynamic therapy in controlling R3230AC mammary tumor growth. We observed a significant delay in growth (from initial to 2 times initial volume) of tumors exposed to periodic irradiation (100 mW/cm²/0.25 h, 1-h dark interval, 100 mW/cm²/0.25 h; total fluence, 180 J/cm²), compared to untreated controls or to tumors receiving continuous irradiation at the same total fluence. Other periodic light treatment regimens, consisting of 3-, 6-, or 24-hr dark intervals, delayed tumor growth but not significantly more than continuous irradiation at the same fluence. A biochemical basis was sought by comparing continuous versus periodic irradiation for effects on mitochondrial or cytosolic enzymes in vivo. Although both cytochrome c oxidase and pyruvate kinase activities were reduced dramatically during the first 24 h by continuous or periodic irradiation schemes, recovery of enzyme activity to initial levels took longer after the periodic irradiation protocol (168 h), compared to the continuous irradiation regimen (72 h). We observed a significantly greater delay in the growth of tumors exposed to 50 mW/cm²/2 h continuously, compared to controls or to tumors exposed to the same total fluence but with light delivered at 100 or 200 mW/cm². The data presented here indicate that the efficacy of photodynamic therapy could be significantly increased by modifications in the delivery of photoradiation.

¹ Supported by USPHS Grants CA36856 and CA46148 from the National Cancer Institute.

² To whom requests for reprints should be addressed, at Department of Biochemistry, Box 607, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642.

Received 6/ 6/90. Accepted 8/20/90.

This article has been cited by other articles:

				W. J. Cottrell, A. D. Paquette, K. R. Keymel, T. H. Foster, and A. R. Oseroff Irradiance-Dependent Photobleaching and Pain in {delta}-Aminolevulinic Acid-Photodynamic Therapy of Superficial Basal Cell Carcinomas Clin. Cancer Res., July 15, 2008; 14(14): 4475 - 4483. [Abstract] [Full Text] [PDF]

				M. Seshadri, D. A. Bellnier, L. A. Vaughan, J. A. Spernyak, R. Mazurchuk, T. H. Foster, and B. W. Henderson Light Delivery over Extended Time Periods Enhances the Effectiveness of Photodynamic Therapy Clin. Cancer Res., May 1, 2008; 14(9): 2796 - 2805. [Abstract] [Full Text] [PDF]

				Z. Xiao, S. Halls, D. Dickey, J. Tulip, and R. B. Moore Fractionated versus Standard Continuous Light Delivery in Interstitial Photodynamic Therapy of Dunning Prostate Carcinomas Clin. Cancer Res., December 15, 2007; 13(24): 7496 - 7505. [Abstract] [Full Text] [PDF]

				B. W. Henderson, S. O. Gollnick, J. W. Snyder, T. M. Busch, P. C. Kousis, R. T. Cheney, and J. Morgan Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of Tumors Cancer Res., March 15, 2004; 64(6): 2120 - 2126. [Abstract] [Full Text] [PDF]

				B. W. Pogue, J. A. O'Hara, E. Demidenko, C. M. Wilmot, I. A. Goodwin, B. Chen, H. M. Swartz, and T. Hasan Photodynamic Therapy with Verteporfin in the Radiation-induced Fibrosarcoma-1 Tumor Causes Enhanced Radiation Sensitivity Cancer Res., March 1, 2003; 63(5): 1025 - 1033. [Abstract] [Full Text] [PDF]

				S. Iinuma, K. T. Schomacker, G. Wagnieres, M. Rajadhyaksha, M. Bamberg, T. Momma, and T. Hasan In Vivo Fluence Rate and Fractionation Effects on Tumor Response and Photobleaching: Photodynamic Therapy with Two Photosensitizers in an Orthotopic Rat Tumor Model Cancer Res., December 1, 1999; 59(24): 6164 - 6170. [Abstract] [Full Text] [PDF]